Your browser doesn't support javascript.
loading
Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic.
Steinhardt, Laura C; Ige, Fehintola; Iriemenam, Nnaemeka C; Greby, Stacie M; Hamada, Yohhei; Uwandu, Mabel; Aniedobe, Maureen; Stafford, Kristen A; Abimiku, Alash'le; Mba, Nwando; Agala, Ndidi; Okunoye, Olumide; Mpamugo, Augustine; Swaminathan, Mahesh; Onokevbagbe, Edewede; Olaleye, Temitope; Odoh, Ifeanyichukwu; Marston, Barbara J; Okoye, McPaul; Abubakar, Ibrahim; Rangaka, Molebogeng X; Rogier, Eric; Audu, Rosemary.
Affiliation
  • Steinhardt LC; Malaria Branch, Division of Malaria and Parasitic Diseases, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Ige F; Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Iriemenam NC; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Greby SM; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Hamada Y; Institute for Global Health, University College London, London, United Kingdom.
  • Uwandu M; Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Aniedobe M; Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
  • Stafford KA; Center for International Health, Education, and Biosecurity, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Abimiku A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Mba N; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Agala N; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
  • Okunoye O; National Reference Laboratory, Nigeria Center for Disease Control, Abuja, Nigeria.
  • Mpamugo A; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
  • Swaminathan M; National Reference Laboratory, Nigeria Center for Disease Control, Abuja, Nigeria.
  • Onokevbagbe E; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Olaleye T; University of Maryland, Baltimore, Abuja, Nigeria.
  • Odoh I; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Marston BJ; University of Maryland, Baltimore, Abuja, Nigeria.
  • Okoye M; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
  • Abubakar I; International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria.
  • Rangaka MX; Division of Malaria and Parasitic Diseases, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Rogier E; Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Audu R; Institute for Global Health, University College London, London, United Kingdom.
J Clin Microbiol ; 59(7): e0051421, 2021 06 18.
Article in En | MEDLINE | ID: mdl-33853839
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Malaria Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: J Clin Microbiol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / Malaria Type of study: Diagnostic_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: J Clin Microbiol Year: 2021 Type: Article Affiliation country: United States